Overview
- 12 inspections across 11 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-08-08.
At a glance
Inspections
12
Sites
11
Observations
0
Career since
Sep 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent Anagni SRL | 8 Aug 2023 | Biologics | |
| Octapharma AB | 14 Jul 2016 | Biologics | On file |
| Takeda Manufacturing Singapore Pte. Ltd. | 15 Sep 2015 | Biologics | |
| Seqirus Inc | 12 Feb 2014 | Biologics | On file |
| Omrix Biopharmacuetical LTD Jerusalem Plant | 28 Feb 2013 | Biologics | On file |
Sites inspected
Catalent Anagni SRLAnagni, Italy1 insp.
Octapharma ABStockholm, Sweden1 insp.
Takeda Manufacturing Singapore Pte. Ltd.Singapore, Singapore1 insp.
Seqirus IncHolly Springs, United States1 insp.
Omrix Biopharmacuetical LTD Jerusalem PlantJerusalem, Israel1 insp.
Co-investigators
Investigators who share inspections with this person.
Jie He2 shared
Randa Melhem2 shared
Viviana R Ramirez1 shared
Erin C Hill1 shared
Michael J Vardon1 shared
Robert D Tollefsen1 shared
Nawab A Siddiqui1 shared
Rachel C Harrington1 shared
Jennifer L Schmidt1 shared
Gang Wang1 shared
Full investigator report
Get the verbatim findings behind Anthony F Lorenzo's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site